REPLY TO THREAD
|
Subject
|
EBOLA Out-of-Control Outbreak in Africa. Fed Halts Vaccine R&D. Agenda 21?
|
User Name
|
|
|
|
|
Font color:
Font:
|
|
|
|
Original Message
|
Page 18, Rockefeller Foundation Report
LOCK-STEP SCENARIO
In 2012, the pandemic that the world had been anticipating for years finally hit.
[link to www.rockefellerfoundation.org]
August 6, 2012 Tekmira Provides Update on Collaboration With U.S. Government's TMT Program
VANCOUVER, British Columbia, Aug. 6, 2012 (GLOBE NEWSWIRE) -- Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR) (TSX:TKM), a leading developer of RNA interference (RNAi) therapeutics, today announced that it has received a temporary stop-work order from the U.S. Department of Defense (DoD) with respect to Tekmira's TKM-Ebola program. Other contractors have received similar notices as the DoD is under recently imposed funding constraints.
"During the two years of our collaboration with the U.S. DoD's Transformational Medical Technologies Program, we have a developed a strong working relationship that has fostered advances in our TKM-Ebola program and our LNP platform. Due to budgetary pressure in the U.S., we understand that the DoD must complete a thorough assessment of its ongoing programs. We expect a decision by September 1, 2012 on the future direction of our collaboration," said Dr. Mark J. Murray, Tekmira's President and CEO.
It is expected that by September 1, 2012, Tekmira will receive notification whether the DoD will cancel the stop-work order; terminate the contract; or extend the stop-work order period, if necessary.
TKM-Ebola is being developed under a contract awarded by the U.S. Government's Transformational Medical Technologies (TMT) Program to advance an RNAi therapeutic utilizing Tekmira's LNP technology to treat Ebola virus infection.
[link to investor.tekmirapharm.com]
|
Pictures (click to insert)
|
| | | | | | | | | | | | | | | | | | | | | | | | | Next Page >> |
|